Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis

This publication has 18 references indexed in Scilit:

• Standardization criteria for the detection of BCR/ABL fusion in interphase nuclei of chronic myelogenous leukemia patients by fluorescence in situ hybridization
  Cancer Genetics and Cytogenetics, 2000
• Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia
  Blood, 2000
• Chronic myeloid leukemia from basics to bedside
  Leukemia, 1999
• Prognostic Significance of c-ABL Methylation in Chronic Myelogenous Leukemia: Still an Open Question
  Blood, 1999
• Location of theBCR-ABL fusion gene on the 9q34 band in two cases of Ph-positive chronic myeloid leukemia
  Genes, Chromosomes and Cancer, 1997
• Improved Sensitivity of BCR-ABL Detection: A Triple-Probe Three-Color Fluorescence In Situ Hybridization System
  Blood, 1997
• The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype [editorial; comment]
  Blood, 1996
• Clinical Relevance of the Breakpoint Sites within the M-BCR in 50 Patients from Argentina with Chronic Myeloid Leukemia
  Leukemia & Lymphoma, 1996
• Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon-α Therapy
  Annals of Internal Medicine, 1995
• The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL
  Cancer Genetics and Cytogenetics, 1993